COVID-19 pandemic shifted epidemiology for cancer screening sites: breast, cervix, colon, and rectum

被引：0

作者：

Ishkinin, Yevgeniy ^{[1
]}

Kaidarova, Dilyara ^{[2
,3
]}

Nazarbek, Serzhan ^{[4
,5
]}

Zhylkaidarova, Alma ^{[6
]}

Ossikbayeva, Saniya ^{[7
]}

Mussina, Kamilla ^{[8
]}

Omarbayeva, Nazgul ^{[9
]}

机构：

[1] Almaty Oncol Ctr, Dept Radiat Therapy, Alma Ata, Kazakhstan

[2] Kazakh Inst Oncol & Radiol, Alma Ata, Kazakhstan

[3] Asfendiyarov Kazakh Natl Med Univ, Alma Ata, Kazakhstan

[4] Club Experts Senate Republ Kazakhstan, Astana, Kazakhstan

[5] Kazakhstan Assoc Healthcare Managers, Astana, Kazakhstan

[6] Kazakh Inst Oncol & Radiol, Dept Screening, Alma Ata, Kazakhstan

[7] Kazakh Inst Oncol & Radiol, Ctr Mol Genet Res, Alma Ata, Kazakhstan

[8] Nazarbayev Univ, Sch Med, Dept Med, Astana, Kazakhstan

[9] Kazakh Radiol & Oncol Inst, Alma Ata, Kazakhstan

来源：

FRONTIERS IN ONCOLOGY | 2025年 / 14卷

关键词：

cancer screening; breast cancer; cervical cancer; colon cancer; rectum cancer; COVID-19; early-onset cancer;

D O I：

10.3389/fonc.2024.1481242

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background This study aimed to assess the epidemiological changes in breast, cervical, colon, and rectal cancers in Kazakhstan before and during COVID-19, including early-onset cancer (EOC) diagnosed between the ages of 20 and 49, using data from the oncological service of the Republic of Kazakhstan for the 2017-2022 period.Methods The cohort comprised patients aged 20 to 49 years (EOC) and 50 years and older [late-onset cancer (LOC)] from the total number of patients diagnosed each year during the study period of 2017 to 2022 for breast, cervical, colon, or rectal cancer. In order to indicate a difference in one-time intervals and characterize the global trend over the entire study period, annual percentage change (APC) and average APC (AAPC) were calculated, respectively.Results Breast cancer detection rates increased by 22.8% for EOC and 15.9% for LOC from 2017 to 2022, and AAPC increased by 4.3% for EOC and 3.6% for LOC. During the COVID-19 restriction period, breast cancer detection rates decreased by 6.1% for EOC and 15.6% for LOC. Cervical cancer detection rates increased by 2.3% for EOC and 7.5% for LOC from 2017 to 2022, and AAPC increased by 0.9% for EOC and 1.6% for LOC. During the COVID-19 restriction period, cervical cancer detection rates decreased by 11.3% for EOC and 3.1% for LOC. Colon cancer detection rates increased by 18.4% for EOC and 14.3% for LOC from 2017 to 2022, and AAPC increased by 3.7% for EOC and 2.9% for LOC. During the COVID-19 restriction period, colon cancer detection rates decreased by 14.4% for EOC and 5.8% for LOC. Rectal cancer detection rates increased by 13.6% for EOC and 19.2% for LOC from 2017 to 2022, and AAPC increased by 3.0% for EOC and by 3.9% for LOC. During the COVID-19 restriction period, rectal cancer detection rates increased by 18.6% for EOC and decreased by 12.0% for LOC.Conclusion The epidemiological indicators of population cancer screening worsened during the COVID pandemic; the detection rate decreased by 6.1% for breast EOC and 11.3% for cervical EOC, while there was an increase by 38.0% in EOC for colon cancer in men and by 8.0% in EOC for rectal cancer in men and 31.1% in women.

引用

页数：13

共 29 条

[1]

Ahmad OB., 2001, Geneva World Heal Organ, V31, P1

[2] Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative Treatment [J].

Cairns, Ashley ;

Jones, V. Morgan ;

Cronin, Kelly ;

Yocobozzi, Margaret ;

Howard, Clifford ;

Lesko, Nadja ;

Chiba, Akiko ;

Howard-McNatt, Marissa .

AMERICAN SURGEON, 2022, 88 (06) :1051-1053

[3] Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J].

Chen, Nanshan ;

Zhou, Min ;

Dong, Xuan ;

Qu, Jieming ;

Gong, Fengyun ;

Han, Yang ;

Qiu, Yang ;

Wang, Jingli ;

Liu, Ying ;

Wei, Yuan ;

Xia, Jia'an ;

Yu, Ting ;

Zhang, Xinxin ;

Zhang, Li .

LANCET, 2020, 395 (10223) :507-513

[4]

Davies Philip, 2023, Asian Pac J Cancer Prev, V24, P1781, DOI 10.31557/APJCP.2023.24.5.1781

[5] The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China [J].

Hui, David S. ;

Azhar, Esam I. ;

Madani, Tariq A. ;

Ntoumi, Francine ;

Kock, Richard ;

Dar, Osman ;

Ippolito, Giuseppe ;

Mchugh, Timothy D. ;

Memish, Ziad A. ;

Drosten, Christian ;

Zumla, Alimuddin ;

Petersen, Eskild .

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 91 :264-266

[6]

Kaidarova DR., 2020, Indicators of the oncology service of the Republic of Kazakhstan, 2019 (statistical and analytical materials), P225

[7]

Kaidarova DR., 2019, Indicators of the oncology service of the Republic of Kazakhstan, 2018 (statistical and analytical materials), P209

[8]

Kaidarova DR., 2021, Indicators of the oncology service of the Republic of Kazakhstan, 2020 (statistical and analytical materials), P370, DOI 10.52532978-601-7548-11-7-2020-1-370

[9]

Kaidarova DR., 2022, Indicators of the oncology service of the Republic of Kazakhstan, 2021 (statistical and analytical materials), P384, DOI [10.52532/1-11-2021-1-384, DOI 10.52532/1-11-2021-1-384]

[10]

Kaidarova DR., 2023, Indicators of the oncology service of the Republic of Kazakhstan, 2022 (statistical and analytical materials), P430, DOI [10.52532/1-09-2023-1-430, DOI 10.52532/1-09-2023-1-430]

← 1 2 3 →